Medical weight loss in Atlanta: how GLP-1 programs actually work

What a GLP-1 actually is

GLP-1 stands for glucagon-like peptide-1 — a hormone your gut naturally releases after meals. It does several useful things at once: signals satiety to your brain, slows the rate at which your stomach empties, prompts insulin release proportional to glucose, and modestly suppresses glucagon. The net effect: you feel full sooner, you stay full longer, and your blood sugar stabilizes.

GLP-1 receptor agonists (the drug class) are synthetic versions designed to last days instead of minutes. Semaglutide (sold as Wegovy for weight loss, Ozempic for diabetes) and tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) are the most prescribed. Tirzepatide additionally activates a second receptor (GIP), which produces somewhat better weight-loss results in head-to-head trials.

The clinical evidence base is large and consistent: in 18-month trials, semaglutide produced an average 15% body-weight reduction; tirzepatide produced 20–22%. These are the largest weight-loss results ever seen from a non-surgical intervention.

Why physician supervision matters

This is the single most important section of this guide. The medication is not the magic — the supervision is. A trained physician does five things a mail-order or telehealth-only program typically can't:

1. Full medical evaluation — thyroid history, gallbladder function, family history of medullary thyroid carcinoma or MEN2 syndrome, mental-health screening, current medications. Some of these are absolute contraindications; some change the dose strategy.
2. Dose titration based on response — there's no single right dose. Some patients tolerate the standard escalation; others need to slow it down or stay at a lower maintenance dose. A flat one-size-fits-all schedule causes most people to drop out.
3. Side-effect management — nausea on day 4 isn't a reason to stop. It's a signal to adjust diet, hydration, or pace. A clinician who answers your texts is the difference between staying on therapy and quitting in week 3.
4. Lifestyle integration — protein targets, resistance training, sleep, alcohol limits. Without these, you'll lose weight and disproportionate amounts of muscle. With them, you preserve metabolism.
5. Off-ramp planning — most clients eventually taper. How you taper, and whether you maintain results, is decided months before you stop.

Who qualifies

The FDA-approved indications for GLP-1 weight-loss prescriptions:

• BMI ≥ 30 — obesity classification
• BMI ≥ 27 with at least one weight-related condition — hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease

Beyond FDA labeling, physician judgment matters. We evaluate full medical history, prior weight-loss attempts, mental health, lifestyle, and goals before deciding whether GLP-1 is right for you — or whether a different intervention (peptide therapy, metabolic workup, behavior-focused plan) is a better fit.

You should NOT take GLP-1 medications if you have: personal or family history of medullary thyroid carcinoma or MEN2 syndrome, severe gastroparesis, or active pancreatitis. Pregnancy and breastfeeding are also exclusions.

A realistic month-by-month timeline

• Weeks 1–4: starting dose. Mild appetite reduction. Some nausea, especially after meals. Most clients lose 1–4 pounds.
• Weeks 4–8: dose increases. Appetite suppression noticeable; food cravings significantly reduced. Side effects often peak around the dose escalation, then fade. Weight loss accelerates.
• Months 2–4: the body adjusts. Most side effects resolve. Weight loss continues steadily — typically 1–2% body weight per month at this stage.
• Months 4–12: the steady-state phase. Weight loss continues but slows as you approach your individual setpoint. This is when consistent protein intake and resistance training matter most for preserving muscle.
• Months 12+: maintenance. Some clients taper to a lower dose; others maintain at full dose. Long-term GLP-1 use is well-tolerated for the patients who need it.

Side effects (honest version)

The marketing materials downplay these. Here's what to actually expect:

• Nausea — most common. Usually mild and intermittent for 4–8 weeks. Eating slowly and stopping at "satisfied" instead of "full" helps significantly.
• Constipation — fluid intake and fiber need to go up immediately. This is universally underestimated.
• Fatigue — sometimes from caloric reduction itself rather than the drug. Adequate protein and electrolytes matter.
• Reflux / heartburn — affects a minority of clients. Sometimes resolved by smaller, slower meals.
• Gallbladder issues — uncommon but real, especially with rapid weight loss. Symptoms (right-upper-belly pain after fatty meals) need same-day evaluation.
• "Ozempic face" — accelerated facial volume loss from rapid weight reduction, not from the drug itself. Strategic dermal-filler placement after stabilizing addresses this.
• Mental health changes — most clients report improved mood and reduced food anxiety. A small minority experience low mood; this should be reported promptly.

Branded vs. compounded

Two paths exist right now:

• Branded — Wegovy (semaglutide), Zepbound (tirzepatide). FDA-approved, manufactured by Novo Nordisk and Eli Lilly respectively. Insurance coverage is improving but still inconsistent. Self-pay is $1,000+ per month.
• Compounded — semaglutide or tirzepatide formulated by a compounding pharmacy under physician prescription. The active drug is the same; the compounded form often includes B12 or other adjuncts. Costs $250–$500 per month. Quality depends entirely on the pharmacy.

Compounded medications are legal under specific FDA conditions and are widely used in supervised programs. The right path depends on cost, insurance, and pharmacy quality. We help clients evaluate both at consultation.

Mail-order pitfalls

The biggest mistakes I see from clients who started elsewhere and came to us mid-program:

• No medical history collected — patients with thyroid or gallbladder concerns shouldn't be on these drugs, and a 5-question telehealth form often misses these.
• No dose individualization — clients escalated too quickly suffer worse side effects, drop out, and lose nothing.
• No protein/training guidance — clients lose 30 pounds, half of which is muscle. They look gaunt rather than healthy.
• No off-ramp plan — clients stop the medication abruptly and regain most of the weight in 6–12 months.
• No accountability for side effects — gallbladder issues, dehydration, and rare but serious reactions need a physician you can actually reach.

Cost breakdown

At Majspa Aesthetics, our medical weight-loss program includes:

• Initial physician consultation and full medical evaluation
• Customized prescription (branded or compounded based on your situation)
• Monthly check-ins for the first 6 months, then quarterly
• Direct messaging access to your provider for side-effect questions
• Lifestyle and protein-target guidance
• Body-composition tracking

Pricing is structured around the medication path you choose. Compounded programs typically run $250–$500/month all-in; branded programs vary based on insurance. We confirm exact pricing at consultation, and CareCredit financing is available for qualifying program packages.

FAQ

---

Continue reading

• How Botox actually works
• Hydrafacial vs. VI Peel — an honest comparison
• Your first laser hair removal in Marietta
• Med spa in Marietta, GA — overview
• Meet your provider — Dr. N. Msimanga, MD

Sources & further reading

• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216.
• NIDDK — Prescription Medications to Treat Overweight & Obesity
• U.S. FDA — Medications Containing Semaglutide